Immunotherapy Advances in Small Cell Lung Cancer

2019 will be a year of change in the healthcare industry but also a great innovation. In this webinar, we will identify ways to help your organization face the year head-on, while also addressing challenges that are influencing the delivery of care.

With the widespread digitization of patient health records, traditional paper and film-based records have been replaced with Electronic Health Records (EHRs). Whether your organization is a large clinical practice with multiple locations, a single facility hospital, or an accountable care organization, EHR solutions can help you streamline workflows and improve your ability to care for patients. But to make the most of today’s innovative EHR offerings, IT teams often resort to piecing together custom infrastructure solutions using separate servers and storage in order to deal with the need for improved application performance.

Learn how to better identify any liability and regulatory risks that may occur on social media. Social media seems to be part of every aspect of our lives, and health care is no exception. In the health care industry, professionals dealing with social media confront unique and critical compliance pitfalls like privacy, security, and HIPAA concerns. This topic will go over how to navigate key compliance issues, such as using social media for marketing, setting social media policies for employees, ownership of social media content, social media as part of the medical record, and how to identify risks and mitigate them by setting up appropriate social media policies. This information will give you the insights and tools you need to identify and minimize regulatory and liability risks linked to social media, and draft your own social media policy using a sample policy and put into place appropriate consequences for potential violations.

Do you need reliable pharmacokinetic data (PK) to evaluate human immunoglobulin or albumin-based therapeutic drug candidates? The humanized FcRn (Hu-FcRn) mouse model enables you to obtain clinically-relevant PK data related to drug half-life. This critically important PK data helps optimize the design of preclinical efficacy studies and to de-risk lead selection.